Platinum Investment Management’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,188
| Closed | -$952K | – | 158 |
|
|
2023
Q1 | $952K | Sell |
12,188
-3,072
| -20% | -$240K | 0.03% | 102 |
|
|
2022
Q4 | $1.27M | Hold |
15,260
| – | – | 0.05% | 94 |
|
|
2022
Q3 | $1.4M | Buy |
15,260
+1,524
| +11% | +$140K | 0.06% | 87 |
|
|
2022
Q2 | $2.06M | Buy |
13,736
+882
| +7% | +$132K | 0.08% | 82 |
|
|
2022
Q1 | $3.12M | Hold |
12,854
| – | – | 0.1% | 68 |
|
|
2021
Q4 | $3.89M | Hold |
12,854
| – | – | 0.11% | 71 |
|
|
2021
Q3 | $5.32M | Sell |
12,854
-1,705
| -12% | -$705K | 0.15% | 63 |
|
|
2021
Q2 | $4.46M | Buy |
14,559
+8,199
| +129% | +$2.51M | 0.1% | 67 |
|
|
2021
Q1 | $1.31M | Hold |
6,360
| – | – | 0.03% | 104 |
|
|
2020
Q4 | $1.27M | Hold |
6,360
| – | – | 0.03% | 107 |
|
|
2020
Q3 | $1.05M | Hold |
6,360
| – | – | 0.03% | 106 |
|
|
2020
Q2 | $1.58M | Buy |
6,360
+2,562
| +67% | +$635K | 0.04% | 95 |
|
|
2020
Q1 | $693K | Hold |
3,798
| – | – | 0.02% | 105 |
|
|
2019
Q4 | $1.1M | Hold |
3,798
| – | – | 0.02% | 83 |
|
|
2019
Q3 | $1.04M | Sell |
3,798
-1,180
| -24% | -$322K | 0.02% | 82 |
|
|
2019
Q2 | $1.87M | Sell |
4,978
-1,207
| -20% | -$454K | 0.04% | 62 |
|
|
2019
Q1 | $1.66M | Hold |
6,185
| – | – | 0.04% | 74 |
|
|
2018
Q4 | $1.32M | Buy |
6,185
+3,784
| +158% | +$805K | 0.04% | 67 |
|
|
2018
Q3 | $1.08M | Buy |
2,401
+848
| +55% | +$380K | 0.03% | 72 |
|
|
2018
Q2 | $630K | Hold |
1,553
| – | – | 0.01% | 82 |
|
|
2018
Q1 | $847K | Buy |
+1,553
| New | +$847K | 0.02% | 73 |
|